Total Neoadjuvant Treatment Bests Surgery in Locally Advanced Rectal Cancer

Colorectal Cancer News

Total Neoadjuvant Treatment Bests Surgery in Locally Advanced Rectal Cancer
Colorectal Cancer (CRC)Malignant Rectal NeoplasmRectal Cancer
  • 📰 Medscape
  • ⏱ Reading Time:
  • 40 sec. here
  • 24 min. at publisher
  • 📊 Quality Score:
  • News: 96%
  • Publisher: 55%

Researchers investigated the efficacy of total neoadjuvant treatment followed by nonoperative management in patients with locally advanced rectal cancer.

Organ preservation may be a viable option for select patients with locally advanced rectal cancer , according to the first results of the NO-CUT trial.

The NO-CUT trial aimed to assess whether nonoperative management negatively affects the risk for distant relapse and to identify predictive biomarkers of treatment outcomes. David Sebag-Montefiore, MD, who was not involved in the NO-CUT trial, served as a discussant on the findings at the meeting. The NO-CUT trial includes a comprehensive translational program to identify biomarkers predictive of clinical response and survival. ctDNA analysis using the Guardant Reveal assay showed promising results, according to Amatu.

"I do think we are on the verge of a new era for organ preservation. A lot of the groundwork has been done, and we now have a platform to build upon to optimize systemic and radiotherapy-based treatments to change the treatment paradigm," he added.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Medscape /  🏆 386. in US

Colorectal Cancer (CRC) Malignant Rectal Neoplasm Rectal Cancer Cancer Of The Rectum Rectal Carcinoma Cancer Malignant Neoplasia Carcinoma Malignant Neoplasm Neoadjuvant Surgery Organ Preservation Biomarker Biological Marker Multi-Biomarker Disease Activity MBDA Multibiomarker Disease Activity Chemotherapy Italy Italian Radiation Therapy Radiotherapy

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Exploratory Data Support Both Adjuvant and Neoadjuvant Nivolumab for NSCLCExploratory Data Support Both Adjuvant and Neoadjuvant Nivolumab for NSCLCInvestigators analyzed patient-level data from the phase 3 CheckMate 77T and 816 trials.
Read more »

Neoadjuvant Immunotherapy Shows Promise for High-Risk HCCNeoadjuvant Immunotherapy Shows Promise for High-Risk HCCNeoadjuvant immunotherapy yielded similar survival and surgical outcomes to upfront surgery in high-risk HCC and could broaden surgical options for traditionally unresectable cases.
Read more »

Detroit Lions Week 2 best bet: Amon-Ra St. Brown bests Tampa Bay secondaryDetroit Lions Week 2 best bet: Amon-Ra St. Brown bests Tampa Bay secondaryAmon-Ra St. Brown over 83.5 rushing and receiving yards is NFL best bet.
Read more »

Czinger bests Koenigsegg's Laguna Seca recordCzinger bests Koenigsegg's Laguna Seca recordDoesn't matter if you win by an inch or a mile - or a tenth of a second...
Read more »

Aryna Sabalenka bests American hope Jessica Pegula for U.S. Open title in New York CityAryna Sabalenka bests American hope Jessica Pegula for U.S. Open title in New York CitySenior Breaking News Reporter
Read more »

Jannik Sinner bests American Taylor Fritz for U.S. Open men's titleJannik Sinner bests American Taylor Fritz for U.S. Open men's titleSenior Breaking News Reporter
Read more »



Render Time: 2025-02-14 22:24:25